SXTC
China SXT Pharmaceuticals, Inc.
$2.57
+13.72%
$98.2M
No data for this timeframe.
Vol
Market Cap$98.2M
Cap SizeMicro Cap
SEC Reports3
Press Releases1
Recent Activity
Jun 5, 2026
SEC
China SXT Pharmaceuticals filed a 424B5 prospectus supplement for an at-the-market (ATM) equity offering of up to $100 m
424B5 — Impact 7/10
May 4, 2026
SEC
China SXT Pharmaceuticals raised $3.5M through a dilutive private placement of 3.5M shares and 3.5M warrants at $1.00 pe
6-K — Impact 7/10
Apr 9, 2026
SEC
China SXT Pharmaceuticals is raising $760,000 through a direct placement of 2 million Class A ordinary shares at $0.38 p
424B5, 6-K — Impact 6/10
Mar 30, 2026
short_volume
Short Volume: SXTC — 56.7% short (0.3M / 0.6M)
Short: 344,008 | Exempt: 2,831 | TRF Vol: 607,142 | Short Ratio: 56.7% | Off-exchange volume (dark p
Mar 23, 2026
Press
China SXT Pharmaceuticals, Inc. (SXTC) announced that its Class A Ordinary Shares will begin trading under the symbol 'S
Impact 3/10
Latest Reports
BEARISH
424B5
7/10
China SXT Pharmaceuticals filed a 424B5 prospectus supplement for an at-the-market (ATM) equity offering of up to $100 m
Jun 5, 2026
BEARISH
6-K
7/10
China SXT Pharmaceuticals raised $3.5M through a dilutive private placement of 3.5M shares and 3.5M warrants at $1.00 pe
May 4, 2026
NEUTRAL
Press
3/10
China SXT Pharmaceuticals, Inc. (SXTC) announced that its Class A Ordinary Shares will begin trading under the symbol 'S
Mar 23, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 0 mixed, 0 neutral. Avg impact: 6.7/10.
BEARISH
424B5
7/10
China SXT Pharmaceuticals filed a 424B5 prospectus supplement for an at-the-market (ATM) equity offe
Jun 5, 2026
BEARISH
6-K
7/10
China SXT Pharmaceuticals raised $3.5M through a dilutive private placement of 3.5M shares and 3.5M
May 4, 2026
BEARISH
424B5, 6-K
6/10
China SXT Pharmaceuticals is raising $760,000 through a direct placement of 2 million Class A ordina
Apr 9, 2026
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Mar 30, 2026
short_volume
Short Volume: SXTC — 56.7% short (0.3M / 0.6M)
Short: 344,008 | Exempt: 2,831 | TRF Vol: 607,142 | Short Ratio: 56.7% | Off-exchange volume (dark pool + OTC)
Mar 23, 2026
announcement
China SXT Pharmaceuticals, Inc. Announces Share Re-classification
<p align="justify">TAIZHOU, China, March 23, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a sp